6 completed, 2 terminated, 1 unknown. 2 Phase 2, 2 Phase 3, 2 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
| Phase 4 | 2 | Completed 2 |
| Phase 1 | 1 | Terminated 1 |
Follow DNA, Ribosomal: new trials by email Literature Review of DNA, Ribosomal trials Research Report on DNA, Ribosomal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants Multicomponent Meningococcal B Vaccine, Meningococcal Group B Vaccine MenB, Meningococcal Group B Vaccine (recombinant deoxyribonucleic acid [rDNA], component, adsorbed) - Meningococcal Immunisation, Healthy Volunteers | Phase 1 | Terminated | Sanofi Pasteur, a Sanofi Company | 576 | 2021-03-29 | 2025-10-10 |
| Vaccination Adjuved Against Hepatitis B in SNS Workers Typed as no Responders to Conventional Vaccines Fendrix suspension for injection Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed). - Hepatitis B, Hepatitis | Phase 4 | Completed | Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León | 67 | 2018-04-13 | 2021-07-08 |
| Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA HBVAXPRO 5µg - Virus Diseases, Hepatitis B | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 751 | 2014-01-01 | 2017-09-11 |
| Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN) Glargine Insulin, Regular insulin - Diabetic Patients With Gastrointestinal Cancer Undergoing Surgery and Receiving Parenteral Nutrition | Phase 4 | Completed | King Faisal Specialist Hospital & Research Center | 61 | 2013-03-01 | 2016-02-25 |
| Treatment of Rett Syndrome With Recombinant Human IGF-1 Recombinant Human Insulin Growth Factor 1 (rhIGF-1), Placebo - Rett Syndrome | Phase 2 | Completed | Boston Children's Hospital | 30 | 2013-01-01 | 2018-03-26 |
| An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A rVIII-SingleChain, Octocog alfa - Hemophilia A | Phase 2 / Phase 3 | Completed | CSL Behring | 175 | 2012-02-01 | 2016-08-09 |
| Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight somatropin (rDNA) - Fetal Growth Retardation | Unknown | Massachusetts General Hospital | 12 | 2005-07-01 | 2011-07-20 | |
| Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature somatropin (rDNA) - Turner Syndrome, Idiopathic Short Stature | Terminated | Massachusetts General Hospital | 1 | 2005-06-01 | 2009-09-29 | |
| Observational Study of Somatropin Treatment in Children Somatropin (recombinant deoxyribonucleic acid [rDNA] origin) - Growth Hormone (GH) Deficiency, Short Stature Homeobox Containing Gene (SHOX) Deficiency | Completed | Eli Lilly and Company | 22845 | 1999-04-01 | 2019-05-13 |
Insulin Resistance (3) · Dwarfism (2) · Hepatitis B (2) · Autism Spectrum Disorder (1) · Fetal Growth Retardation (1) · Hemophilia A (1) · Hepatitis (1) · Hepatitis, Viral, Human (1) · Hyperglycemia (1) · Hyperphagia (1) · Rett Syndrome (1) · Turner Syndrome (1) · Virus Diseases (1)
Massachusetts General Hospital (2) · Sanofi Pasteur, a Sanofi Company (2) · Boston Children's Hospital (1) · CSL Behring (1) · Eli Lilly and Company (1) · Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León (1) · King Faisal Specialist Hospital & Research Center (1)
United States (5) · Italy (2) · Spain (2) · Australia (1) · Austria (1) · Canada (1) · Czechia (1) · Germany (1) · Hungary (1) · Japan (1) · Lebanon (1) · Malaysia (1) · Netherlands (1) · Philippines (1) · Poland (1)
Lynne L Levitsky, MD (2) · Hakeam A Hakeam, MS., BCPS (1) · Jose L. Bravo-Grande, MD PhD (1) · Mustafa Sahin, MD, PhD (1)
PMID 21490076, PMID 23689058, PMID 24088548, PMID 27330001, PMID 28575299, PMID 28624307, PMID 30201821, PMID 30219920, PMID 33334613
2016 (1), 2023 (1)